Autologus Stem Cell Transplantation for Cancers: India: 2017Shreeniwas Shilawant Raut*
Gujarat Cancer and Research Institute, B.J. Medical College, Ahmedabad, 380016, India
- Corresponding Author:
- Shreeniwas Shilawant Raut, MD.DM
Gujarat Cancer and Research Institute
B.J. Medical College, Ahmedabad, 380016, India
Tel: +91 9099407702
E-mail: [email protected]
Received Date: January 27, 2017; Accepted Date: April 13, 2017; Published Date: April 22, 2017
Citation: Raut SS (2017) Autologus Stem Cell Transplantation for Cancers: India: 2017. J Blood Disord Transfus 8:379. doi: 10.4172/2155-9864.1000379
Copyright: © 2017 Raut SS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
India is a well-known destination for health tourism including hematopoietic stem cell transplantation for various cancers like multiple myeloma, Hodgkin and non-hodgkin lymphoma. Hematopoietic stem cell transplant is cheaper in India as compared to developed countries and there is a huge cost difference. Here, the numbers of stem cell transplant centres and transplant activity are increasing. In this paper, we summarise present status of autologus stem cell transplant for various cancers in India including the basics of autologus stem cell transplant procedure and reported statistics. This will add to scarcely reported literature in this topic as well as encourage the Indian stem cell transplant activity.